CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Cash flows from operating activities:
Net income (loss)	$ 2,069	$ (14,013)
Adjustments to reconcile net income (loss) to cash provided by operating activities:
Depreciation and amortization	44,455	47,772
Long-lived asset impairment	4,710	8,245
Inventory write-downs	465	490
Amortization of deferred financing costs	1,585	2,170
Amortization of debt discount	344	319
Amortization of terminated interest rate swaps	184	37
Debt extinguishment costs	0	291
Interest rate swaps	257	505
Stock-based compensation expense	1,794	2,153
Non-cash restructuring charges	0	457
Provision for doubtful accounts	620	369
Gain on sale of property, plant and equipment	(1,195)	(757)
Deferred income tax provision	295	174
Amortization of contract costs	2,884	0
Changes in assets and liabilities:
Accounts receivable, trade	4,539	10,125
Inventory	(1,187)	(2,014)
Other current assets	601	145
Contract costs	(8,078)	0
Accounts payable and other liabilities	8,091	(1,575)
Deferred revenue	224	72
Other	(202)	(223)
Net cash provided by continuing operations	62,455	54,742
Net cash provided by discontinued operations	0	45
Net cash provided by operating activities	62,455	54,787
Cash flows from investing activities:
Capital expenditures	(69,972)	(30,915)
Proceeds from sale of property, plant and equipment	14,845	5,766
Proceeds from insurance	136	0
Net cash used in investing activities	(54,991)	(25,149)
Cash flows from financing activities:
Proceeds from borrowings of long-term debt	155,830	810,500
Repayments of long-term debt	(146,636)	(817,000)
Payments for debt issuance costs	(2,316)	(14,459)
Payments for settlement of interest rate swaps that include financing elements	(205)	(581)
Dividends to Archrock stockholders	(8,532)	(8,458)
Distributions to noncontrolling partners in the Partnership	(11,766)	(10,446)
Proceeds from stock options exercised	0	939
Proceeds from stock issued under our employee stock purchase plan	223	0
Purchases of treasury stock	(1,041)	(2,180)
Contribution from Exterran Corporation	0	19,720
Net cash used in financing activities	(14,443)	(21,965)
Net increase (decrease) in cash and cash equivalents	(6,979)	7,673
Cash and cash equivalents at beginning of period	10,536	3,134
Cash and cash equivalents at end of period	$ 3,557	$ 10,807